| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Clinical Officer
1 company
Steik Jason Paul is a Chief Clinical Officer at PNTG. Recent filings cover 0 purchases and 1 sale. Those positions are worth an estimated $591K at current prices.
Steik Jason Paul's largest disclosed position is in PNTG as Chief Clinical Officer, worth about $591K. The recent filings there lean toward selling, a net 1,394 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | PNTG The Pennant Group, Inc. | Chief Clinical Officer | Sell | 1,394 | $38.52 | $53,699.67 | -8.4% |